Physician profile
Ami Parikh
NPI 1477790533
$946.90
in general payments reported to CMS, 2019-2025
13 companies · $430 in 2025
The $430 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.00 · 2020: $22.46 · 2021: $6.99 · 2022: $142 · 2023: $103 · 2024: $179 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $209.57 | 2025 | Senza |
| Ivoclar Vivadent, INC. | $141.54 | 2022 | |
| Nuo Therapeutics | $132.16 | 2025 | |
| Convatec INC. | $124.99 | 2024 | |
| Abbott Laboratories | $118.44 | 2019-2023 | Diamondback Peripheral |
| Curonix LLC | $67.59 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Organogenesis INC. | $31.42 | 2019 | |
| Integra Lifesciences Corporation | $30.12 | 2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Nevro Corp. | $23.62 | 2024 | Senza |
| Wright Medical Technology, INC. | $22.46 | 2020 | |
| Reprise Biomedical, INC. | $20.92 | 2025 | Miro3d |
| Osteomed LLC | $17.08 | 2019 | |
| Orthofix Medical, INC. | $6.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ami Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.